共 170 条
- [1] Langley M(1989)Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in cerebrovascular disease Drugs 37 669-99
- [2] Sorkin EM(1994)Bioanalytics of nimodipine—an overview of methods Pharmazie 49 130-9
- [3] Mück W(1998)Analytical study of photodegradation of inclusion complexes of nimodipine with alpha-, gamma-cyclodextrin, methyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin Drug Dev Ind Pharm 24 197-200
- [4] Bode H(2004)Separation of neutral dihydropyridines and their enantiomers using electrokinetic chromatography J Pharmacent Biomed 36 799-805
- [5] Mielcarek J(2001)Solubility study of nimodipine inclusion complexation with alpha- and beta-cyclodextrin and betasome substituted cyclodextrins J Incl Phenom Macro 39 215-7
- [6] Eeckhant AV(1995)2-hydroxypropyl-b-cyclodextrin complexation with ursodeoxycholic acid Int J Pharm 118 77-83
- [7] Robert M(1980)Pharmaceutical interactions in dosage forms and processing. XIX. Dissolution kinetics for coprecipitates of indomethacin with polyvinylpyrrolidone Chem Pharm Bull 28 3304-9
- [8] Michotte Y(2002)Study on the inclusion complexes of bromazepam with β-and β-hydroxypropyl-cyclodextrins J Pharm Biomed Anal 28 761-9
- [9] Kopecky F(2010)Application of cyclodextrin in drug delivery Int J of Pharm Wor Res 1 1-21
- [10] Kopecka B(2003)Improved aqueous solubility of crystalline astaxanthin (3,3′-dihydroxy-β, β-carotene-4,4′-dione) by captisol® (sulfobutyl ether β-cyclodextrin) J Pharm Sci 92 922-6